Clopidogrel bisulfate

CAS: 135046-48-9

Ref. 3D-FC11669

Produktinformation

• Name: Clopidogrel bisulfate
• Synonyme: (2S)-(2-chlorophenyl)(6,7-dihydrothieno[3,2-c]pyridin-5(4H)-yl)ethanoic acid sulfate (1:1), (RS)-Clopidogrel bisulfate, (±)-Methyl (2-chlorophenyl)(6,7-dihydro-4H-thieno[3,2-c]pyrid-5-yl)acetate hydrogen sulfate salt (1:1), Clopidogerl Bisulfate, Clopidogrel Bisulfate, Clopidogrel Bisulfate I, Clopidogrel Bisulfate II, Clopidogrel Bisulfate, FormI/FormII, Clopidogrel Hydrogen Sulphate, Clopidogrel Hydrogensulfate, Clopidogrel Sulphate, Clopidogrel bisulphate, Clopidogrel bisulphate Ⅰ/Ⅱ, Clopidogrel sulfate, Methyl (+)-(S)-A-(2-Chlorophenyl)-6,7-Dihydrothieno[3,2-C]Pyridine-5(4H)Acetate, Hydrogen Sulfate Salt, Methyl 2-(2-Chlorophenyl)-2-(6,7-dihydro-4H-thieno[3,2-c]pyridin-5-yl)acetate hydrogen sulfate, Thieno[3,2-c]pyridine-5(4H)-acetic acid, α-(2-chlorophenyl)-6,7-dihydro-, methyl ester, sulfate (1:1)
• CAS: 135046-48-9

Beschreibung

Clopidogrel is a potent inhibitor of the platelet aggregation. It reduces blood clotting by inhibiting the ADP receptor on the surface of platelets, thereby inhibiting the aggregation and adhesion of platelets. Clopidogrel has been shown to be effective in preventing thrombosis, myocardial infarction (heart attack), and stroke. Clopidogrel inhibits the activity of cytochrome P450 3A4 (CYP3A4) and p2Y 12 receptors. Clopidogrel has been shown to have synergic effects with nonsteroidal anti-inflammatory drugs (NSAIDs). The polymorphic nature of Clopidogrel can be monitored using a liquid chromatography-tandem mass spectrometry (LC-MS/MS) method for quantification in biological samples such as human serum and plasma.

• Marke: Biosynth

Chemische Eigenschaften

• Molekulargewicht: 419.9 g/mol
• Formel: C₁₆H₁₆ClNO₂S·H₂O₄S
• Reinheit: Min. 95%
• InChl: InChI=1S/C16H16ClNO2S.H2O4S/c1-20-16(19)15(12-4-2-3-5-13(12)17)18-8-6-14-11(10-18)7-9-21-14;1-5(2,3)4/h2-5,7,9,15H,6,8,10H2,1H3;(H2,1,2,3,4)/t15-;/m0./s1
• InChI Key: InChIKey=FDEODCTUSIWGLK-RSAXXLAASA-N
• SMILES: COC(=O)[C@H](c1ccccc1Cl)N1CCc2sccc2C1.O=S(=O)(O)O